Tournezy Jeflie, Léger Claire, Klonjkowski Bernard, Gonzalez-Dunia Daniel, Szelechowski Marion, Garenne André, Mathis Stéphane, Chevallier Stéphanie, Le Masson Gwendal
Neurocentre Magendie INSERM U1215, Université de Bordeaux, 33000 Bordeaux, France.
UMR 1161 Virologie, INRA, ANSES, Ecole Nationale Vétérinaire d'Alfort, 94700 Maisons-Alfort, France.
Int J Mol Sci. 2024 Nov 28;25(23):12789. doi: 10.3390/ijms252312789.
In amyotrophic lateral sclerosis (ALS), early mitochondrial dysfunction may contribute to progressive motor neuron loss. Remarkably, the ectopic expression of the Orthobornavirus bornaense type 1 (BoDV-1) X protein in mitochondria blocks apoptosis and protects neurons from degeneration. Therefore, this study examines the neuroprotective effects of X protein in an ALS mouse model. We first tested in vitro the effect of the X-derived peptide (PX3) on motoneurons primary cultures of SOD1 mice. The total intracellular adenosine triphosphate (ATP) content was measured after incubation of the peptide. We next tested in vivo the intramuscular injection of X protein using a canine viral vector (CAV2-X) and PX3 intranasal administrations in mice. Disease onset and progression were assessed through rotarod performance, functional motor unit analysis via electrophysiology, and motor neuron survival by immunohistochemistry. The results showed that in vitro PX3 restored the ATP level in SOD1 motor neurons. In vivo, treated mice demonstrated better motor performance, preserved motor units, and higher motor neuron survival. Although life expectancy was not extended in this severe mouse model of motor neuron degeneration, the present findings clearly demonstrate the neuroprotective potential of X protein in a model of ALS. We are convinced that further studies may improve the therapeutic impact of X protein with optimized administration methods.
在肌萎缩侧索硬化症(ALS)中,早期线粒体功能障碍可能导致运动神经元进行性丧失。值得注意的是,博尔纳病毒1型(BoDV-1)X蛋白在线粒体中的异位表达可阻止细胞凋亡并保护神经元免于退化。因此,本研究考察了X蛋白在ALS小鼠模型中的神经保护作用。我们首先在体外测试了X衍生肽(PX3)对SOD1小鼠运动神经元原代培养物的影响。在肽孵育后测量细胞内三磷酸腺苷(ATP)的总含量。接下来,我们在体内测试了使用犬病毒载体(CAV2-X)肌肉注射X蛋白和对小鼠鼻内施用PX3的效果。通过转棒试验评估疾病的发作和进展,通过电生理学进行功能性运动单位分析,并通过免疫组织化学评估运动神经元的存活情况。结果表明,在体外,PX3恢复了SOD1运动神经元中的ATP水平。在体内,接受治疗的小鼠表现出更好的运动性能、保留的运动单位和更高的运动神经元存活率。尽管在这个严重的运动神经元退化小鼠模型中预期寿命没有延长,但目前的研究结果清楚地证明了X蛋白在ALS模型中的神经保护潜力。我们相信,进一步的研究可能会通过优化给药方法来提高X蛋白的治疗效果。